|
2008 Psychoeducation Workshops |
 |
Toronto, ON
Wednesday, Junuary 16, 2008 |
2007 Psychoeducation Workshops |
 |
Montreal, QC Friday, April 27, 2007
|
 |
Vancouver, BC Saturday, April 14, 2007 |
CANMAT
Bipolar Updates at
CPA CPD Institute: Collaborative Forums in Mental Health |
 |
Ottawa, ON
Friday, March 30, 2007 |
 |
Halifax, NS
Friday, April 27, 2007 |
 |
Vancouver, BC Friday, May 4
2007 |
 |
Montreal, QC Friday, June 1, 2007 |
 |
Toronto, ON Friday, June 8, 2007 |
|
| |
|
|
 |
 |
| |
|
TIPS TO GET DEPRESSED
PATIENTS WELL
A patient's compliance
with medication is one of the most crucial factors in effective treatment
of depression. However, encouraging patient adherence - especially in
the setting of depression where features of the illness mitigate against
good adherence - is where the art of medical practice comes into play.
Here are a few secrets for helping depressed patients get well.
|
| 1. |
Explain the
illness. The degree to which patients accept the idea that depression
is a biochemical condition is vital to them buying into the treatment
plan. An intelligent, frank and honest discussion about changes
in brain chemistry which occur or accompany stressful events can
often help patients accept that they need to take antidepressant
medication to restore physiological imbalances.
|
| 2. |
Identify
target symptoms. By identifying target symptoms as tangible
markers of a patient's progress, physicians and their patients can
better monitor progress and, as identified symptoms improve, confidence
in treatment should be enhanced. The most helpful symptoms to target
are sleep disturbances, appetite changes, energy levels and anxiety,
as these are usually the first to improve, followed by an improvement
in mood.
|
| 3. |
Explain why
the medication is needed. This may involve a reiteration of
the physical nature of depression, along with what symptoms are
likely to improve first, when and how. Because there is a tendency
for patients to focus on side effects of the medication, physicians
need to emphasize that the benefits of taking the medication come
as part of a continuum of treatment for depression, and that therapeutic
effects are an expected part of that continuum provided patients
persevere.
|
| 4. |
Disclose
the most common side effects and when to expect them. Patients
should be reassured that most side effects are mild and transient;
that they usually occur when the medication is being started or
when the dose is increased, and that they generally resolve with
time. Some side effects occur early on in treatment (as soon as
the first pill is taken); others, such as sexual dysfunction, may
show up early but not become an issue until patients resume interest
in sexual activity. The initial choice of antidepressant thus must
take into account possible short as well as long-term side effects
to ensure patient compliance.
|
| 5. |
Explore patient
resistance to medications. By exploring often learned attitudes
related to illness and the sick role, physicians have an opportunity
to address these attitudes. A change in the patient's thinking about
medications may well enhance compliance. As importantly, patients
who are unhappy with their response to antidepressants are more
likely to stop taking the medications and experience discontinuation
symptoms as a consequence. Physicians therefore need to make sure
that patients understand that they are unlikely to notice any change
in symptoms until the 2nd to 4th week on treatment - at which point,
sleep, appetite and energy should improve. Mood may take up to 8
weeks to improve significantly. If patients don't expect early results,
they are less likely to stop taking the medication due to lack of
efficacy. They also need to be reminded to take the medication every
day, as prescribed, even after they begin to feel better, and to
check with their doctor before they stop taking the medication.
If side effects are troublesome, there are many other antidepressants
from which to choose and a better pharmacological fit may be found.
|
| 6. |
Be empathetic.
Physicians have a responsibility not only to treat an illness but
to support their patient, and to convey that support through empathy
and understanding of their patients' experience. Once patients feel
they are understood, they are much more likely to trust the physician
and his or her judgement- and hence, more likely to persist with
treatment, even when benefits are not immediately apparent.
|
| 7. |
Convey hope
and optimism. The power of hope in the recovery of the patient
should not be underestimated. Depressed patients are by definition
unable to be optimistic or hopeful, and they may attribute the delayed
onset of antidepressant action as some fault of their own and abandon
treatment as yet another futile exercise. Given the effectiveness
of current antidepressant medications, physicians can honestly convey
their confidence in the treatment plan to patients, and reassure
them that they are extremely likely to get better, provided they
comply with their treatment plan.
|
| 8. |
Discuss complementary
therapies: Many patients are greatly interested in complementary
therapies (eg. St. John's Wort) for treatment of depression. A frank
discussion of complementary therapies shows patients that the physician
is both knowledgeable and open to the idea of alternative treatments
and that the chosen medication was carefully considered against
other potential alternatives. A discussion of alternative approaches
also allows patients to feel as if they are actively involved in
their treatment. (Link
to interview with Dr Jacques Bradwejn)
|
| 9. |
Establish
a therapeutic alliance. The first few weeks of treating depression
are critical, as this is when the therapeutic alliance is established
between physician and patient and the basis for ongoing treatment
is set. During these initial weeks, anxiety and sleep disturbances
are common problems associated not only with depression but also
initiation of treatment. Physicians thus need to educate the patient
about the illness and its consequences, and set expectations for
treatment in a supportive way. These strategies not only help cement
the therapeutic alliance, but enhance compliance especially through
the initial and often difficult few weeks of treatment. Once the
therapeutic alliance has been established, physicians and patients
can work together through problems and conflicts in a collaborative
way that should enhance adherence to therapy and optimize the likelihood
of a successful outcome.
|
| 10. |
Follow the
patient closely. Close follow-up in the initial phase of antidepressant
therapy is essential to monitor response as well as adverse effects.
Patients who are seen only monthly on initiation of treatment may
develop side effects and stop taking the medication between visits,
which could precipitate a relapse. The uncertainty that the illness
and its course can have in the early part of treatment necessitates
regular, consistent visits in order to ensure successful resolution
of symptoms.
|
| 11. |
Factor
in features of depression. Certain clinical features of depression
influence compliance and treatment outcome. These include the severity
and duration of illness; chronicity has been implicated in poor compliance.
Comorbid conditions should also be taken into account when planning
a treatment strategy for patients. If a patient has a comorbid substance
abuse problem, for example, ideally no treatment should be initiated
until the substance abuse problem is controlled. Exaggerated guilt
in patients may also make them feel unworthy of treatment; personality
features including suspiciousness, lack of acceptance of the illness
and fear of stigmatization need to be addressed at the outset to enhance
compliance. |
|
|
Please see:
Section V: "Specific
Pharmacological Issues"
CANMAT Guidelines for the Diagnosis and Pharmacological Treatment
of Depression
(1st Edition Rev., 1999)
P. 50
Diagnosing
Depressive Disorders Menu
Treating
Depressive Disorders Menu
|
|
|
 |
| Over one million Canadians suffer from some form of depressive illness. |
|
 |
 |
 |
 |
|
|
| |
| |
|
| |
|
|
 |